STOKE THERAPEUTICS, INC. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 12.8 USD | +10.82% |
|
+7.20% | +143.35% |
| May. 07 | Canaccord Genuity Adjusts Price Target on Stoke Therapeutics to $20 From $21, Maintains Buy Rating | MT |
| May. 06 | Earnings Flash (STOK) STOKE THERAPEUTICS Reports Q1 Revenue $4.2M | MT |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes
End-of-day quotes
Compared values
| Sector | Change | 5d. change | 1st Jan change | 1-year change | 5-years change | Capi. | ST | MT | LT | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| STOKE THERAPEUTICS, INC. | Other Biotechnology & Medical Research | +10.82% | +7.20% | +143.35% | +11.89% | - | 667M |  |  | |
Technical Rankings Surperformance
- Stock Market
- Equities
- STOK Stock
- Charts Stoke Therapeutics, Inc.
- Comparison Chart
